Literature DB >> 29398833

Diagnostic Dilemmas in Aggressive Large B Cell Neoplasms with Enigmatic Immunohistochemical Profile: How Far Should We Investigate?

Neha Singh1, Sunil Pasricha1, Narendra Agrawal2, Jatin S Gandhi1, Ajit Panaych1, Anurag Mehta1, Rayaz Ahmed2, Dinesh Bhurani2.   

Abstract

Entities:  

Year:  2017        PMID： 29398833      PMCID： PMC5786632          DOI： 10.1007/s12288-017-0839-3

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  9 in total

1.  The CBFA2T3/ACSF3 locus is recurrently involved in IGH chromosomal translocation t(14;16)(q32;q24) in pediatric B-cell lymphoma with germinal center phenotype.

Authors:  Itziar Salaverria; Takashi Akasaka; Stefan Gesk; Monika Szczepanowski; Birgit Burkhardt; Lana Harder; Christine Damm-Welk; Ilske Oschlies; Wolfram Klapper; Martin J S Dyer; Reiner Siebert
Journal:  Genes Chromosomes Cancer       Date:  2012-04       Impact factor: 5.006

2.  Blimp-1 protein and Hans classification on prognosis of diffuse large B-cell lymphoma and their interrelation.

Authors:  Yan Song; Zhi Cao; Ling Li; Hong-Tu Zhang; Xun Zhang
Journal:  Chin J Cancer       Date:  2010-09

3.  t(11;14) multiple myeloma: a subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome.

Authors:  Gang An; Yan Xu; Lihui Shi; Dehui Zou; Shuhui Deng; Weiwei Sui; Zhenqing Xie; Mu Hao; Hong Chang; Lugui Qiu
Journal:  Leuk Res       Date:  2013-08-05       Impact factor: 3.156

4.  Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?

Authors:  Hervé Avet-Loiseau; Florent Malard; Loic Campion; Florence Magrangeas; Catherine Sebban; Bruno Lioure; Olivier Decaux; Thierry Lamy; Laurence Legros; Jean-Gabriel Fuzibet; Mauricette Michallet; Bernadette Corront; Pascal Lenain; Cyrille Hulin; Claire Mathiot; Michel Attal; Thierry Facon; Jean-Luc Harousseau; Stephane Minvielle; Philippe Moreau
Journal:  Blood       Date:  2010-10-20       Impact factor: 22.113

5.  Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype.

Authors:  Santiago Montes-Moreno; Ana-Rosa Gonzalez-Medina; Socorro-María Rodriguez-Pinilla; Lorena Maestre; Lydia Sanchez-Verde; Giovanna Roncador; Manuela Mollejo; Juan F García; Javier Menarguez; Carlos Montalbán; M Carmen Ruiz-Marcellan; Eulogio Conde; Miguel A Piris
Journal:  Haematologica       Date:  2010-04-23       Impact factor: 9.941

Review 6.  Aggressive B-cell lymphomas: how many categories do we need?

Authors:  Jonathan W Said
Journal:  Mod Pathol       Date:  2012-11-16       Impact factor: 7.842

Review 7.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

8.  IRF8 is associated with germinal center B-cell-like type of diffuse large B-cell lymphoma and exceptionally involved in translocation t(14;16)(q32.33;q24.1).

Authors:  Marianne Tinguely; Svenja Thies; Simona Frigerio; Tanja Reineke; Dimitri Korol; Dieter R Zimmermann
Journal:  Leuk Lymphoma       Date:  2013-06-12

9.  t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs.

Authors:  T Narita; A Inagaki; T Kobayashi; Y Kuroda; T Fukushima; M Nezu; S Fuchida; H Sakai; N Sekiguchi; I Sugiura; Y Maeda; H Takamatsu; N Tsukamoto; D Maruyama; Y Kubota; M Kojima; K Sunami; T Ono; M Ri; K Tobinai; S Iida
Journal:  Blood Cancer J       Date:  2015-02-27       Impact factor: 11.037
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.